| GWW |
Report |
Daily Organic CC Growth |
BEAT |
pred ~12.5% vs. cons 11.75% |
MEDIUM |
| GWW |
Report |
Operating EPS (diluted, adj.) |
BEAT |
pred ~$11.42 vs. cons $11.28 |
MEDIUM |
| GWW |
Report |
Total Company Operating Margin |
MISS |
pred ~15.15% vs. cons 15.47% |
MEDIUM |
| GWW |
Guide |
FY 2026 EPS (op. diluted) (FY 2026) |
UNCHANGED |
guide mid ~$45.75 vs. cons $45.69 |
MEDIUM |
| GWW |
Guide |
FY 2026 Revenue (FY 2026) |
UNCHANGED |
guide ~10%-12.5% org. CC vs. cons $19.475B |
MEDIUM |
| GWW |
Guide |
Q3 2026 Daily Org. CC Growth (Q3 2026) |
BETTER |
guide ~10-11% vs. cons 9.74% |
MEDIUM |
| GWW |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.5% |
— |
MEDIUM |
| GWW |
Return |
5-day cumulative residual |
-2.5% (FADE) |
FADE — margin miss pulls near-term estimates down; CFO departure overhang suppresses re-rating; no new catalyst until September pricing window |
MEDIUM |